Remifemin Preventing the Climacteric Symptoms in Breast Cancer
Status:
Completed
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
LHRH-a is an important hormone treatment in breast cancer especially in high-risk hormone
receptor-positive patients or hormone receptor-negative but needing ovarian function
protecting. The climacteric symptoms caused by LHRH-a are often and prominent, which is a
common clinical problem.